Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors

Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood Jr.
Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
Sean Ekins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dayna C. Mankowski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis J. Hoover
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Lawton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith L. Treadway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. James Harwood Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 35 no. 3 493-500
DOI 
https://doi.org/10.1124/dmd.106.013888
PubMed 
17194716

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received November 13, 2006
  • Accepted December 26, 2006
  • Published online February 26, 2007.

Article Versions

  • Earlier version (December 28, 2006 - 05:32).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Sean Ekins1,
  2. Dayna C. Mankowski2,
  3. Dennis J. Hoover,
  4. Michael P. Lawton,
  5. Judith L. Treadway and
  6. H. James Harwood, Jr.
  1. Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut
  1. Address correspondence to:
    Dr. Sean Ekins, Vice President, Computational Biology, ACT LLC, 601 Runnymede Ave., Jenkintown, PA 19046. E-mail ekinssean{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 2017015118
Sep 2017172725
Oct 2017032065
Nov 201705125
Dec 201704119
Jan 201813218
Feb 201833420
Mar 201812925
Apr 201802625
May 201802919
Jun 201812934
Jul 201802417
Aug 201802421
Sep 20180155
Oct 201812822
Nov 20182814
Dec 201866158
Jan 20197515
Feb 201910414
Mar 20194423
Apr 20191725
May 201913114
Jun 2019637
Jul 20191716
Aug 20191723
Oct 201935143
Nov 20192628
Dec 201948110
Jan 20202503
Feb 20202017
Mar 20201225
May 20202244
Jun 20202626
Jul 20201204
Aug 2020703
Sep 20201203
Oct 20202505
Nov 20201817
Dec 202027110
Jan 20214064
Feb 20212915
Mar 20211210
Apr 20211226
May 202126310
Jun 20212338
Jul 20211523
Aug 20211324
Sep 20211128
Oct 20211314
Nov 20211415
Dec 20213229
Jan 2022712
Feb 202216311
Mar 202217213
Apr 20227311
May 202216116
Jun 20221218
Jul 20221617
Aug 20221827
Sep 20221611
Oct 20222024
Nov 20221115
Dec 2022811
Jan 20234010
Feb 20231110
Mar 20231325

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 35 (3)
Drug Metabolism and Disposition
Vol. 35, Issue 3
1 Mar 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors

Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
Drug Metabolism and Disposition March 1, 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors

Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
Drug Metabolism and Disposition March 1, 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics